ライフサイエンスコーパス: asymptomatic bacteriuria

1 ted willingness to prescribe antibiotics for asymptomatic bacteriuria.

2 encourage more testing for and treatment of asymptomatic bacteriuria.

3 ion; for UTI, 43.9% were due to treatment of asymptomatic bacteriuria.

4 s on the benefits and harms of screening for asymptomatic bacteriuria.

5 ould not undergo screening and treatment for asymptomatic bacteriuria.

6 heir approach to a hypothetical patient with asymptomatic bacteriuria.

7 on; for UTIs, 43.9% were due to treatment of asymptomatic bacteriuria.

8 likely to prescribe antibiotic treatment for asymptomatic bacteriuria.

9 chronic colonization that is associated with asymptomatic bacteriuria.

10 ere less likely to prescribe antibiotics for asymptomatic bacteriuria.

11 onephritis strains (53% of isolates) than in asymptomatic bacteriuria (32%) or fecal/commensal (12.5%

12 (57 human commensal, 32 animal commensal, 54 asymptomatic bacteriuria, 45 complicated UTI, 38 uncompl

13 confirmed urinary tract infection (UTI) and asymptomatic bacteriuria (AB) in relation to diabetes me

14 the prevalence and clinical significance of asymptomatic bacteriuria (AB) in women with autoimmune r

15 Little is known about the role of asymptomatic bacteriuria (AB) treatment in young women a

16 infections (rUTIs) are routinely treated for asymptomatic bacteriuria (AB), but the consequences of t

17 s after human inoculation with the prototype asymptomatic bacteriuria (ABU) strain E. coli 83972, and

18 ttle is known about bacteria associated with asymptomatic bacteriuria (ABU) with regard to urinary tr

19 ) and 29 E. coli isolates from patients with asymptomatic bacteriuria (ABU).

20 lactiae causes both symptomatic cystitis and asymptomatic bacteriuria (ABU); however, growth characte

21 e unnecessary screening for and treatment of asymptomatic bacteriuria aid in antibiotic stewardship.

22 oss all ages) have the highest prevalence of asymptomatic bacteriuria, although rates increase with a

23 urious, reflect confounding due to untreated asymptomatic bacteriuria among women who were not given

24 r catheterized patients: catheter-associated asymptomatic bacteriuria and catheter-associated urinary

25 Experimental delineation of asymptomatic bacteriuria and CAUTI informs different str

26 The survey described a male patient with asymptomatic bacteriuria and changes in urine character.

27 lts are caused by an increased prevalence of asymptomatic bacteriuria and frequent use of urinary cat

28 Asymptomatic bacteriuria and pyuria in healthy women oft

29 o evaluate the prevalence and persistence of asymptomatic bacteriuria and pyuria in women at high ris

30 Asymptomatic bacteriuria and symptomatic urinary tract i

31 cessation, malaria prevention, treatment of asymptomatic bacteriuria, and treatment of syphilis), if

32 Trial evidence on harms of asymptomatic bacteriuria antibiotic treatment was limite

33 chronic colonization, which is analogous to asymptomatic bacteriuria, are independent events that re

34 rcent of occasions on which a culture showed asymptomatic bacteriuria, as compared with 1 percent of

35 he microbiologic evaluation of patients with asymptomatic bacteriuria, as well as indications for ant

36 s to antibiotic overuse through treatment of asymptomatic bacteriuria (ASB) and long durations of the

37 Differential diagnosis of asymptomatic bacteriuria (ASB) and urinary tract infecti

38 surgical site contamination, but the role of asymptomatic bacteriuria (ASB) before elective surgery a

39 itive impairment, and the high prevalence of asymptomatic bacteriuria (ASB) complicate the diagnosis

40 Asymptomatic bacteriuria (ASB) is a common finding in ma

41 Antibiotic stewardship for asymptomatic bacteriuria (ASB) is an important quality i

42 ecific urinary symptoms are often absent and asymptomatic bacteriuria (ASB) is prevalent.

43 ecific urinary symptoms are often absent and asymptomatic bacteriuria (ASB) is prevalent.

44 Hospitalized patients with asymptomatic bacteriuria (ASB) often receive unnecessary

45 ith FT as initial treatment for lower UTI or asymptomatic bacteriuria (ASB) or as stepdown treatment

46 he difference was driven by a higher rate of asymptomatic bacteriuria (ASB) post-treatment in patient

47 ably contrast with the clinical condition of asymptomatic bacteriuria (ASB), characterized by signifi

48 delines recommend withholding antibiotics in asymptomatic bacteriuria (ASB), including among patients

49 he urogenital tract in a phenomenon known as asymptomatic bacteriuria (ASB).

50 ation of the human bladder with a prototypic asymptomatic bacteriuria-associated bacterium, Escherich

51 Screening for asymptomatic bacteriuria can identify patients for whom

52 tcomes and that treatment of screen-detected asymptomatic bacteriuria can reduce the incidence of pye

53 oli strain, whereas recurrent infections and asymptomatic bacteriuria commonly result from urinary tr

54 a period of six months for the occurrence of asymptomatic bacteriuria (defined as at least 10(5) colo

55 Screening and treatment for asymptomatic bacteriuria during pregnancy was associated

56 Asymptomatic bacteriuria events (urine cultures with col

57 Asymptomatic bacteriuria events were most commonly cause

58 Recent evidence helps differentiate asymptomatic bacteriuria from symptomatic UTI.

59 /ml group B Streptococcus is significant for asymptomatic bacteriuria in a pregnant woman.

60 s and prescribe antibiotics for treatment of asymptomatic bacteriuria in an effort to reduce infectio

61 d complicated), catheter-associated UTI, and asymptomatic bacteriuria in both women and men.

62 ertainty that screening for and treatment of asymptomatic bacteriuria in nonpregnant adults has no ne

63 The USPSTF recommends against screening for asymptomatic bacteriuria in nonpregnant adults.

64 The USPSTF recommends against screening for asymptomatic bacteriuria in nonpregnant adults.

65 Asymptomatic bacteriuria in older women should not be tr

66 ertainty that screening for and treatment of asymptomatic bacteriuria in pregnant persons has moderat

67 evidence continues to support screening for asymptomatic bacteriuria in pregnant women, but not in o

68 hey would prescribe antibiotic treatment for asymptomatic bacteriuria in the absence of an indication

69 cribe inappropriate antibiotic treatment for asymptomatic bacteriuria in the absence of risk factors.

70 The difference was driven by a lower rate of asymptomatic bacteriuria in the subgroup of ertapenem-tr

71 males are routinely screened and treated for asymptomatic bacteriuria in the United States.

72 reatment of cUTIs, driven by a lower rate of asymptomatic bacteriuria in those who received ciproflox

73 Asymptomatic bacteriuria in young women is common but ra

74 adverse outcomes in the setting of untreated asymptomatic bacteriuria include pregnant women and pati

75 idence of harms associated with treatment of asymptomatic bacteriuria (including adverse effects of a

76 often with a narrow-spectrum antibiotic, and asymptomatic bacteriuria is best left untreated.

77 Asymptomatic bacteriuria is common in young women, but l

78 Asymptomatic bacteriuria is common, and screening for th

79 Asymptomatic bacteriuria is defined as two consecutive v

80 Antibiotic treatment for asymptomatic bacteriuria is not recommended in guideline

81 Screening and treatment of asymptomatic bacteriuria is not recommended in the follo

82 Asymptomatic bacteriuria is present in an estimated 1% t

83 Asymptomatic bacteriuria is transient in older women, of

84 h risk of recurrent urinary tract infection, asymptomatic bacteriuria is uncommon and, when present,

85 creening nonpregnant women with diabetes for asymptomatic bacteriuria is unlikely to produce benefits

86 e pyelonephritis), lower UTI (cystitis), and asymptomatic bacteriuria, is useful for numerous reasons

87 E. coli 83972 is an asymptomatic bacteriuria isolate successfully used as a

88 ive care unit setting, is very difficult, as asymptomatic bacteriuria may be difficult to differentia

89 Asymptomatic bacteriuria occurs, irrespective of pyuria,

90 ve UPEC, defined as isolates associated with asymptomatic bacteriuria or bladder infection (cystitis)

91 No new evidence on screening men for asymptomatic bacteriuria or on harms of screening was fo

92 t recommendations not to screen for or treat asymptomatic bacteriuria or pyuria in healthy, nonpregna

93 causing acute cystitis, recurrent cystitis, asymptomatic bacteriuria, or pyelonephritis could progre

94 Among 12 trials of asymptomatic bacteriuria screening and treatment during

95 Asymptomatic bacteriuria should be differentiated from s

96 In general, asymptomatic bacteriuria should not be treated, and trea

97 ormalities, whereas in cases of cystitis and asymptomatic bacteriuria the focus should be on bladder

98 The prevalence of asymptomatic bacteriuria (the proportion of urine cultur

99 The clinical spectrum of UTIs ranges from asymptomatic bacteriuria, to symptomatic and recurrent U

100 Benefits of asymptomatic bacteriuria treatment in nonpregnant adult

101 Five RCTs of asymptomatic bacteriuria treatment in nonpregnant adults

102 TF recommends screening pregnant persons for asymptomatic bacteriuria using urine culture.

103 itive predictive value of pyuria for E. coli asymptomatic bacteriuria was 4%.

104 Asymptomatic bacteriuria was associated with the same ri

105 as compared with 1 percent of occasions when asymptomatic bacteriuria was not found (P<0.001).

106 Persistent asymptomatic bacteriuria with the same E. coli strain wa

107 reduce unnecessary antimicrobial therapy for asymptomatic bacteriuria without significant additional

108 ordered and antimicrobial prescriptions for asymptomatic bacteriuria, without any significant impact